Shahir Aziz

Dr. Shahir Aziz

German University in Cairo, GUC, Egypt
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SAShahir Aziz
Shahir Aziz
RSRegina Scherlieβ
Regina Scherlieβ
HSHartwig Steckel
Hartwig Steckel
Oseltamivir phosphate (OP) is an antiviral drug available only as oral therapy for the treatment of influenza and as a potential treatment option when in combination with other medication in the fight against the corona virus disease (COVID-19) pneumonia. In this study, OP was formulated as a dry powder for inhalation, which allows drug targeting to the site of action and potentially reduces the dose, aiming a more efficient therapy. Binary formulations were based on micronized excipient particles acting like diluents, which were blended with the drug OP. Different excipient types, excipient ratios, and excipient size distributions were prepared and examined. To investigate the feasibility of delivering high doses of OP in a single dose, 1:1, 1:3, and 3:1 drug/diluent blending ratios have been prepared. Subsequently, the aerosolization performance was evaluated for all prepared formulations by cascade impaction using a novel medium-resistance capsule-based inhaler (UNI-Haler). Formulations with micronized trehalose showed relatively excellent aerosolization performance with highest fine-particle doses in comparison to examined lactose, mannitol, and glucose under similar conditions. Focusing on the trehalose-based dry-powder inhalers’ (DPIs) formulations, a physicochemical characterization of extra micronized grade trehalose in relation to the achieved performance in dispersing OP was performed. Additionally, an early indication of inhaled OP safety on lung cells was noted by the viability MTT assay utilizing Calu-3 cells.

28 April 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
FMFayrouz Mustafa
Fayrouz Mustafa
Mohammad Abdel-HalimMohammad Abdel-Halim
Mohammad Abdel-Halim
RARadwa Abdel-Moniem
Radwa Abdel-Moniem
SAShahir Aziz
Shahir Aziz
SDSarah S. Darwish
Sarah S. Darwish
STSalma N. Tammam
Salma N. Tammam

19 September 2023 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
AUA.M. Uwimana
A.M. Uwimana
NHNassim Essabah Haraj
Nassim Essabah Haraj
SAShahir Aziz
Shahir Aziz
ACA. Chadli
A. Chadli

23 October 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
KNKarin Naguib
Karin Naguib
AGAlaa A. Gad
Alaa A. Gad
AKArwa Kadri
Arwa Kadri
RARadwa Abdel-Moniem
Radwa Abdel-Moniem
MAMohammad Abdel-Halim
Mohammad Abdel-Halim
SAShahir Aziz
Shahir Aziz